Zalba Sara, Ten Hagen Timo L M
Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Cancer Treat Rev. 2017 Jan;52:48-57. doi: 10.1016/j.ctrv.2016.10.008. Epub 2016 Nov 9.
Cancer is a complex disease involving numerous biological processes, which can exist in parallel, can be complementary, or are engaged when needed and as such can replace each other. This redundancy in possibilities cancer cells have, are fundamental to failure of therapy. However, intrinsic features of tumor cells and tumors as a whole provide also opportunities for therapy. Here we discuss the unique and specific makeup and arrangement of cell membranes of tumor cells and how these may help treatment. Interestingly, knowledge on cell membranes and associated structures is present already for decades, while application of membrane modification and manipulation as part of cancer therapy is lagging. Recent developments of scientific tools concerning lipids and lipid metabolism, opened new and previously unknown aspects of tumor cells and indicate possible differences in lipid composition and membrane function of tumor cells compared to healthy cells. This field, coined Lipidomics, demonstrates the importance of lipid components in cell membrane in several illnesses. Important alterations in cancer, and specially in resistant cancer cells compared to normal cells, opened the door to new therapeutic strategies. Moreover, the ability to modulate membrane components and/or properties has become a reality. Here, developments in cancer-related Lipidomics and strategies to interfere specifically with cancer cell membranes and how these affect cancer treatment are discussed. We hypothesize that combination of lipid or membrane targeted strategies with available care to improve chemotherapy, radiotherapy and immunotherapy will bring the much needed change in treatment in the years to come.
癌症是一种复杂的疾病,涉及众多生物过程,这些过程可以并行存在、相互补充,或在需要时发挥作用,因此可以相互替代。癌细胞所具有的这种可能性的冗余,是治疗失败的根本原因。然而,肿瘤细胞和整个肿瘤的内在特征也为治疗提供了机会。在这里,我们讨论肿瘤细胞细胞膜的独特和特定组成及排列方式,以及这些如何有助于治疗。有趣的是,关于细胞膜及相关结构的知识已经存在了几十年,而作为癌症治疗一部分的膜修饰和操纵的应用却滞后了。有关脂质和脂质代谢的科学工具的最新进展,揭示了肿瘤细胞新的、以前未知的方面,并表明与健康细胞相比,肿瘤细胞的脂质组成和膜功能可能存在差异。这个领域被称为脂质组学,它证明了细胞膜中的脂质成分在几种疾病中的重要性。与正常细胞相比,癌症尤其是耐药癌细胞中的重要改变,为新的治疗策略打开了大门。此外,调节膜成分和/或特性的能力已经成为现实。在这里,我们将讨论癌症相关脂质组学的进展以及特异性干扰癌细胞膜的策略,以及这些如何影响癌症治疗。我们假设,将脂质或膜靶向策略与现有治疗方法相结合以改善化疗、放疗和免疫治疗,将在未来几年带来急需的治疗变革。